A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma

The purpose of this study was to compare the response rate, overall and 1-year survival in patients with advanced melanoma treated with a standard therapy, dacarbazine and interferon-alpha (DTIC/IFN), or combination chemotherapy, consisting of dacarbazine, BCNU, cisplatin and tamoxifen (DBCT). Treat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Middleton, M R, Lorigan, P, Owen, J, Ashcroft, L, Lee, S M, Harper, P, Thatcher, N
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2000
Assuntos:
Regular Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2363341/
https://ncbi.nlm.nih.gov/pubmed/10735499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.1999.1056
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados